48 related articles for article (PubMed ID: 16517087)
1. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease.
Roberts TJ; Price J; Williams SC; Modo M
Neuroscience; 2006; 139(4):1187-99. PubMed ID: 16517087
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.
Mu S; Wang J; Zhou G; Peng W; He Z; Zhao Z; Mo C; Qu J; Zhang J
PLoS One; 2014; 9(7):e101185. PubMed ID: 25054283
[TBL] [Abstract][Full Text] [Related]
3. Cell-based treatments for huntington's disease.
Dunnett SB; Rosser AE
Int Rev Neurobiol; 2011; 98():483-508. PubMed ID: 21907097
[TBL] [Abstract][Full Text] [Related]
4. Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.
Nicoleau C; Viegas P; Peschanski M; Perrier AL
Neurotherapeutics; 2011 Oct; 8(4):562-76. PubMed ID: 21976138
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington's disease.
Islam J; So KH; Kc E; Moon HC; Kim A; Hyun SH; Kim S; Park YS
Stem Cell Res Ther; 2021 Nov; 12(1):585. PubMed ID: 34809707
[TBL] [Abstract][Full Text] [Related]
6. STIM1, STIM2, and PDI Participate in Cellular Fate Decisions in Low Energy Availability Induced by 3-NP in Male Rats.
Iranipour N; Babaei-Balderlou F; Maleki A; Moslemi M; Khodagholi F
Neurotox Res; 2021 Oct; 39(5):1459-1469. PubMed ID: 34173958
[TBL] [Abstract][Full Text] [Related]
7. Creatine supplementation improves neural progenitor cell survival in Huntington's disease.
Andres RH; Wallimann T; Widmer HR
Brain Circ; 2016; 2(3):133-137. PubMed ID: 30276289
[TBL] [Abstract][Full Text] [Related]
8. Grafted Neural Stem Cells Show Lesion-Specific Migration in Radiation-Injured Rat Brains.
Bai SM; Wang Q; Yu XL; Chen T; Yang J; Shi JT; Tsai RY; Huang H
RSC Adv; 2018; 8(11):5797-5805. PubMed ID: 29963303
[TBL] [Abstract][Full Text] [Related]
9. Cell-based technologies for Huntington's disease.
Haddad MS; Wenceslau CV; Pompeia C; Kerkis I
Dement Neuropsychol; 2016; 10(4):287-295. PubMed ID: 29213471
[TBL] [Abstract][Full Text] [Related]
10. Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?
Precious SV; Zietlow R; Dunnett SB; Kelly CM; Rosser AE
Neurochem Int; 2017 Jun; 106():114-121. PubMed ID: 28137534
[TBL] [Abstract][Full Text] [Related]
11. Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges.
Kerkis I; Haddad MS; Valverde CW; Glosman S
Stem Cell Res Ther; 2015 Dec; 6():232. PubMed ID: 26667114
[TBL] [Abstract][Full Text] [Related]
12. Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.
Fink KD; Crane AT; Lévêque X; Dues DJ; Huffman LD; Moore AC; Story DT; Dejonge RE; Antcliff A; Starski PA; Lu M; Lescaudron L; Rossignol J; Dunbar GL
Stem Cells Transl Med; 2014 May; 3(5):620-31. PubMed ID: 24657963
[TBL] [Abstract][Full Text] [Related]
13. Cannabidivarin is anticonvulsant in mouse and rat.
Hill AJ; Mercier MS; Hill TD; Glyn SE; Jones NA; Yamasaki Y; Futamura T; Duncan M; Stott CG; Stephens GJ; Williams CM; Whalley BJ
Br J Pharmacol; 2012 Dec; 167(8):1629-42. PubMed ID: 22970845
[TBL] [Abstract][Full Text] [Related]
14. Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.
El-Akabawy G; Rattray I; Johansson SM; Gale R; Bates G; Modo M
BMC Neurosci; 2012 Aug; 13():97. PubMed ID: 22876937
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging.
Aggarwal M; Duan W; Hou Z; Rakesh N; Peng Q; Ross CA; Miller MI; Mori S; Zhang J
Neuroimage; 2012 May; 60(4):2086-95. PubMed ID: 22342677
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with hereditary ataxia.
Yang WZ; Zhang Y; Wu F; Zhang M; Cho SC; Li CZ; Li SH; Shu GJ; Sheng YX; Zhao N; Tang Y; Jiang S; Jiang S; Gandjian M; Ichim TE; Hu X
J Transl Med; 2011 May; 9():65. PubMed ID: 21575250
[TBL] [Abstract][Full Text] [Related]
17. Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury.
Obenaus A; Dilmac N; Tone B; Tian HR; Hartman R; Digicaylioglu M; Snyder EY; Ashwal S
Ann Neurol; 2011 Feb; 69(2):282-91. PubMed ID: 21387373
[TBL] [Abstract][Full Text] [Related]
18. Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.
Huang H; Chen L; Sanberg P
Cell Med; 2010 Jan; 1(1):15-46. PubMed ID: 21359168
[TBL] [Abstract][Full Text] [Related]
19. Long-term fate of allogeneic neural stem cells following transplantation into injured spinal cord.
Xu L; Xu CJ; Lü HZ; Wang YX; Li Y; Lu PH
Stem Cell Rev Rep; 2010 Mar; 6(1):121-36. PubMed ID: 20012713
[TBL] [Abstract][Full Text] [Related]
20. Grafting neural precursor cells promotes functional recovery in an SCA1 mouse model.
Chintawar S; Hourez R; Ravella A; Gall D; Orduz D; Rai M; Bishop DP; Geuna S; Schiffmann SN; Pandolfo M
J Neurosci; 2009 Oct; 29(42):13126-35. PubMed ID: 19846700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
